Lisa M. Mandrusiak is an associate in the firm's Litigation practice group. With a background in molecular biology and genetics, she has a deep understanding of the sciences and technologies involved in her clients' chemical, biochemical, biomedical and pharmaceutical inventions.
In addition to litigating cases in federal courts, Ms. Mandrusiak advises her clients on litigation procedure and strategies, litigation avoidance, and the overall protection, exploitation, and enforcement of global patent portfolios. Ms. Mandrusiak's experience with international patent laws and prosecution enables her to better understand and communicate with foreign clients when strategizing and explaining U.S. patent laws.
Prior to attending law school, Ms. Mandrusiak worked as a Patent Technology Specialist at Shusaku Yamamoto Patent Attorneys in Osaka, Japan where she prosecuted hundreds of patent applications in a variety of countries including Japan, Europe, and the United States and advised clients on successful strategies for managing international intellectual property portfolios. During law school, Ms. Mandrusiak worked as a contract associate at Verrill Dana, LLP in Portland, Maine prosecuting patents and advising on intellectual property litigation matters.
“Balancing Open Source Paradigms and Traditional Intellectual Property Models to Optimize Innovation, ” Maine Law Review, 2010, Vol. 63, page 303.
•“Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor, ” Human Molecular Genetics, 2003, Vol. 12, page 1497.
•ABA/BNA Award for Excellence in the Study of Intellectual Property Law (2011)
•Wernick Prize for Legal Writing for the best legal scholarship submitted by a student (2011)
July 28, 2015 - Article Design Patent Litigations Chart Their Own Course
October 6, 2014 - Article Automatic Stay of Litigation Pending Inter Partes Review?: A Simple Proposal for Solving the Patent Troll Riddle ABA Landslide
December 2012 - Article Will PTAB Decisions In Interferences Declared After September 15, 2012 Be Reviewable In Court? 19 Intellectual Property Today No. 12 at page 32
August 2012 - Article 'Discovering' Trade Secrets: The Devil is in the Details BNA's Patent, Trademark & Copyright Journal, 84 PTCJ 492, 07/20/2012
July 2012 - Article How Will Kappos v. Hyatt Impact 35 USC 146 Actions? 19 Intellectual Property Today No. 7 at page 22
March 4, 2015 - In The News
Fed. Circ. Urged To Revive Wal-Mart Slipper IP Fight
October 6, 2014 - Firm News
Automatic Stay of Litigation Pending Inter Partes Review?: A Simple Proposal for Solving the Patent Troll Riddle
April 15, 2014 - Firm News
Oblon Spivak to Host 7th Annual AIPLA Women in IP Networking Event
September 12, 2013 - Firm News
The Ordinary Designer Trumps The Ordinary Observer in High Point Design v. Buyer's Direct
June 14, 2013 - Blog Post
Supreme Court Holds cDNA, But Not Isolated Genes, Patentable
August 16, 2012 - Blog Post
Status Quo: The Federal Circuit Affirms Gene Patentability In Myriad